FDA
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Announces 2025 Annual Results
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals finds Babesia in 24% of chronic fatigue patients
-
-
-
-
-
-
-
H.C. Wainwright Assumes 60 Degrees Pharmaceuticals Inc (SXTP) at Buy
-
-
-
-
-
-
-
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria
-
-
-
-
-
-
-
60 Degrees Pharmaceuticals plans FDA submission for canine babesiosis drug
-
322,203 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

